Jubilant Generics Limited - Company Profile

It is a pharma public limited foreign company incorporated in india based in Noida, Uttar Pradesh, India, established in 2013.
2013 Noida, Uttar Pradesh, India Active
Last Updated:
Access Report
About Jubilant Generics Limited

Jubilant Generics Limited, a active public limited foreign company incorporated in india, was established on 25 November 2013 in Noida, Uttar Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24100UP2013FLC060821. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.58 Cr.

It upholds a compliant status. Employing 1,106 professional, Its leadership includes Arvind Chokhany (Director), Gayatri Taragi (Director), Jaidev Sanjeev Rajpal (Managing Director). Past directors included Gurpartap Singh Sachdeva, Arvind Chokhany, Shyam Sunder Bhartia. It holds ₹500.00 Cr open charges and ₹810.00 Cr settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot 1A, Sector 16A, Institutional Area, Noida, Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100UP2013FLC060821

  • Registration Number

    060821

  • Incorporation Date

    25 November 2013

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.58 Cr

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.58 Cr
  • Company Age 12 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 500.00 Cr
  • Satisfied Charges ₹ 810.00 Cr
  • Revenue Growth **** -74.67%
  • Profit Growth **** -1618.59%
  • Ebitda **** -196.88%
  • Net Worth -53.06%
  • Total Assets -49.95%
Company report

Jubilant Generics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Jubilant Generics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jubilant Generics Limited?
Current Directors
Name Designation Appointment Date Status
Arvind Chokhany Director 03 Jun 2021 Current
Gayatri Taragi Director 21 May 2024 Current
Jaidev Sanjeev Rajpal Managing Director 11 Oct 2022 Current
Shirish Gundopant Belapure Director 20 Jun 2024 Current
Jasdeepsingh Gurdeepsingh Sood Whole-Time Director 14 May 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2021 Past
Pramod Abcsdd Director 25 Sep 2015 Past
Pramod Abcsdd Director 10 Oct 2016 Past
Pramod Abcsdd Additional Director 22 Aug 2016 Past
Pramod Abcsdd Director 01 Apr 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jubilant Generics.

Jubilant Generics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.67% decrease. The company also saw a substantial fall in profitability, with a 1618.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 53.06%.

Jubilant Generics revenue growth over time
Jubilant Generics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -74.67%
*******
*******
*******
*******
Revenue from Operations
*******
 -74.62%
*******
*******
*******
*******
Total Assets
*******
 -49.95%
*******
*******
*******
*******
Profit or Loss
*******
 -1618.59%
*******
*******
*******
*******
Net Worth
*******
 -53.06%
*******
*******
*******
*******
EBITDA
*******
 -196.88%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jubilant Generics?

In 2022, Jubilant Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,000,000,000.00

Satisfied Charges

₹8,100,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 500.00 Cr
Latest Charge Details
Date Lender Amount Status
09 Jan 2015 Others ₹500.00 Cr Open
05 Feb 2016 Indusind Bank Ltd. ₹100.00 Cr Satisfied
30 Sep 2014 Il & Fs Trust Company Limited ₹130.00 Cr Satisfied
23 Sep 2014 Export Import Bank Of India ₹30.00 Cr Satisfied
30 Jul 2014 The Ratnakar Bank Limited ₹50.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Jubilant Generics?

Jubilant Generics has a workforce of 1106 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jubilant Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Generics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jubilant Generics
Recent Activity within the Organization
  • Annual General Meeting

    Jubilant Generics Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Jubilant Generics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    Shikha Aggarwal was appointed as a Cfo was appointed as a Cfo on 01 Aug 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Shirish Gundopant Belapure was appointed as a Director was appointed as a Director on 20 Jun 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Director Appointment

    Progress on Gayatri Taragi was appointed as a Director was appointed as a Director on 21 May 2024 & has been associated with this company since 1 year 9 months . was documented.

  • Director Appointment

    Progress on Jaidev Sanjeev Rajpal was appointed as a CEO was appointed as a CEO on 11 Oct 2022 & has been associated with this company since 3 years 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jubilant Generics Limited?

The CIN of Jubilant Generics Limited is U24100UP2013FLC060821.

Where is Jubilant Generics Limited headquartered?

Jubilant Generics Limited is headquartered at Plot 1A, Sector 16A, Institutional Area, Noida, Noida, Uttar Pradesh, 201301.

When was Jubilant Generics Limited incorporated?

Jubilant Generics Limited was incorporated on 25 November 2013.

Who are the current directors of Jubilant Generics Limited?

The current directors of Jubilant Generics Limited are

What is the primary industry of Jubilant Generics Limited?

The primary industry of Jubilant Generics Limited is Manufacturing.

Is Jubilant Generics Limited a listed company?

Jubilant Generics Limited is unlisted.

What is the capital structure of Jubilant Generics Limited?

The authorized capital of Jubilant Generics Limited is ₹3.00 Cr, and the paid-up capital is ₹2.58 Cr.

What is the compliance status of Jubilant Generics Limited?

The compliance status of Jubilant Generics Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available